Uncategorized
Featured Stories
DaVita Names New Leaders to Accelerate Care Transformation
DaVita Inc. to Participate in Fireside Chat with Wolfe Research
DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
-
DaVita Inc. 1st Quarter 2023 Results
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2023. “In the first quarter, we performed well on our key metrics and our results benefited from…
-
DaVita Celebrates Corporate Citizenship Achievements, Releases its 2022 Community Care Report
DaVita Inc. today published its 2022 Community Care Report, reinforcing its long-standing commitment to corporate citizenship and highlighting meaningful progress made toward meeting the 2025…
-
DaVita Inc. to Participate in the BofA Securities Healthcare Conference 2023
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the BofA Securities Healthcare Conference 2023 on…
-
DaVita Inc. Schedules 1st Quarter 2023 Investor Conference Call
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 8, 2023, at 5:00 p.m. Eastern Time. The company plans to…
-
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered…